| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.1 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |